High Court Rules Against India Device Maker In Procurement Case
This article was originally published in PharmAsia News
A high court in India’s financial hub of Mumbai ruled in favor of a state's interest in procuring coronary stents through a bidding system, rejecting a challenge by Vascular Concepts, which makes and imports the stents and other devices.
You may also be interested in...
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.
The German biotech has developed its COVID-19 vaccine in record-breaking time, but artificial intelligence could help accelerate drug discovery over the longer term.
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.